Medicinova MNOV Insider Ownership

NASDAQ MNOV
$1.39 +0.03 (+2.56%)
As of: Oct 21, 2026 · 1:10 PM EDT

Insider Holdings by Owner

4.86Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
9.88%
▲+7.26% pp QoQ
Shares Held by Insiders
4.86Mn
filed for Sep 2026
▲+276.92% QoQ
Shares Outstanding
49.22Mn
49,221,246 shares
Direct Holdings
0
Indirect: 4.86Mn
Net Shares Traded (QoQ)
+3.57Mn
net buying in Sep 2026
Insiders Holding Shares
1
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Over the past year, MNOV insiders sold $1.73 million of stock (640K shares) on the open market and bought none.

Form 4 Holdings

Insiders Holding MNOV

Insiders 1
Shares held 4.86Mn
Of outstanding 9.88%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Investment Partners Pte. Ltd. 3D Other 0 4,862,047 4,862,047 100.0% 29 Sep, 2026

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

304 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
25 Sep, 2026 Investment Partners Pte. Ltd. 3D Other Disposed S 640,000 $2.70 $1.73Mn 4,862,047 Indirect
23 Jun, 2026 Hideki Nagao Director Acquired A 44,500 $0.00 $0 44,500 Direct
23 Jun, 2026 Nicole Lemerond Director Acquired A 44,500 $0.00 $0 44,500 Direct
23 Jun, 2026 Carolyn Beaver Director Acquired A 44,500 $0.00 $0 44,500 Direct
16 Jan, 2026 Kazuko Matsuda Chief Medical Officer Acquired A 350,000 $0.00 $0 350,000 Direct
16 Jan, 2026 Yuichi Iwaki President And Ceo Acquired A 450,000 $0.00 $0 450,000 Direct
17 Jun, 2025 Carolyn Beaver Director Acquired A 20,000 $0.00 $0 20,000 Direct
17 Jun, 2025 Hideki Nagao Director Acquired A 20,000 $0.00 $0 20,000 Direct
17 Jun, 2025 Nicole Lemerond Director Acquired A 20,000 $0.00 $0 20,000 Direct
12 Feb, 2025 Yuichi Iwaki President And Ceo Acquired A 100,000 $0.00 $0 100,000 Direct
12 Feb, 2025 Carolyn Beaver Director Acquired A 24,500 $0.00 $0 24,500 Direct
12 Feb, 2025 Kazuko Matsuda Chief Medical Officer Acquired A 100,000 $0.00 $0 100,000 Direct
12 Feb, 2025 Hideki Nagao Director Acquired A 24,500 $0.00 $0 24,500 Direct
12 Feb, 2025 Nicole Lemerond Director Acquired A 24,500 $0.00 $0 24,500 Direct
07 Jan, 2025 Yuichi Iwaki President And Ceo Acquired A 400,000 $0.00 $0 400,000 Direct
07 Jan, 2025 Kazuko Matsuda Chief Medical Officer Acquired A 300,000 $0.00 $0 300,000 Direct
11 Jun, 2024 Carolyn Beaver Director Acquired A 20,000 $0.00 $0 20,000 Direct
11 Jun, 2024 Nicole Lemerond Director Acquired A 20,000 $0.00 $0 20,000 Direct
11 Jun, 2024 Hideki Nagao Director Acquired A 20,000 $0.00 $0 20,000 Direct
09 Jan, 2024 Geoffrey Obrien Vice President Acquired A 84,000 $0.00 $0 84,000 Direct